TriSalus Life Sciences, Inc. — Form D

TriSalus Life Sciences, Inc. of WESTMINSTER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-10. The offering totals $42.1M, of which $15.3M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
DIANE PARKSDirectorSAN DIEGO, CA
Simone SongDirectorWESTMINSTER, CO
James ChomasDirectorLongmont, CO
James ChomasExecutive OfficerLongmont, CO
Sean MurphyDirectorSan Diego, CA
Sean MurphyExecutive OfficerSan Diego, CA
Mary T SzelaDirectorWestminster, CO
Mary T SzelaExecutive OfficerWestminster, CO
Gene McGrevinDirectorWestminster, CO
John L TullisDirectorWestminster, CO
Mats L WahlstromDirectorWestminster, CO
Kerry HicksDirectorWestminster, CO
Anil SinghalDirectorWestminster, CO
Raj L MistryExecutive OfficerWestminster, CO
Beverly L HussDirectorWestminster, CO
Simone R SongDirectorWestminster, CO
Anthony R ScaleseExecutive OfficerWestminster, CO
John R TullisDirectorWestminster, CO
Gene R McGrevinDirectorWestminster, CO
James E ChomasDirectorWestminster, CO
James E ChomasExecutive OfficerWestminster, CO
Karen J CassidyDirectorWestminster, CO
Karen J CassidyExecutive OfficerWestminster, CO
Ginger L GrahamDirectorWestminster, CO
Mats R WahlstromDirectorDenver, CO

Other filings by this issuer (7)

FiledFormOfferingSold
2022-11-10D$23.5M$23.5M
2022-11-10D$81.4M$81.4M
2017-03-07D$15.0M$12.9M
2015-11-05D/A$15.0M$15.0M
2015-06-23D$14.1M$11.0M
2013-09-16D$21.3M$16.4M
2011-04-26D$6.7M$3.7M

More